Abridge
The one conversation that matters.
Pittsburgh, PA, United States
Abridge is an AI-powered platform that automatically generates structured clinical notes from patient-physician conversations. Using generative AI, it listens ambiently to the conversation and creates a real-time, accurate summary in the required format for the electronic health record (EHR), saving doctors hours of administrative work each day.
Source: Digital.Health
Digital.Health provided this information. To learn more and get deep data on digital health companies, please visit them here.
Visit Digital.Health →
Only accessible to MedStartr community members.
Join nowHow We Help
Only accessible to MedStartr community members.
Join nowProblem Statement
Physician burnout is a crisis, largely driven by the overwhelming burden of clinical documentation. Doctors spend more time on paperwork than with patients, leading to exhaustion, errors, and a decline in the quality of care. Existing solutions are often clunky and don't fit naturally into the patient-physician conversation.
Core Technology
Generative AI for Clinical Documentation
Key Differentiators
Focus on ambient, conversational AI that integrates seamlessly into the clinical workflow. Proprietary dataset from over 200,000 clinical encounters. Real-time note generation and structuring. Backed by major health systems and top-tier VCs.
Clinical Focus
Primary Care, Specialty Care
Target Customers
Hospitals, Health Systems, large physician groups.
Product Stage
GA
Company Info
- Business Model
- B2B2C
- Founded
- 2018
- Total Funding
- Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now - Website
- www.abridge.com/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Abridge's technology is built on a proprietary dataset from more than 200,000 clinical encounters. Their AI is continuously trained and evaluated by medical professionals to ensure accuracy. They have demonstrated a 99%+ accuracy rate in identifying medical terms and medications. A study published in the New England Journal of Medicine Catalyst showed Abridge saved clinicians over 3 hours per week on average.
IP Protection
Patents Pending
Only accessible to MedStartr community members.
Join nowWhat do you think of Abridge?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now